Ph.D.
Clinical Molecular Geneticist; Associate Clinical Professor of Pathology; Medical Director, Clinical Molecular Diagnostic Laboratory
1994 - Bogazici University, Istanbul, Turkey, Ph.D., Human Genetics
1999 - Fellow of American College of Medical Genetics and Genomics
1994-1999 - Post Doctoral Fellow and Researcher, UCLA, Los Angeles, CA
Milhan Telatar, PhD, is a board-certified clinical molecular geneticist and director of the Clinical Molecular Diagnostic Laboratory at City of Hope® Cancer Center Duarte, where she oversees the lab’s scientific, technical, regulatory and operational functions. Dr. Telatar has successfully designed, developed and implemented numerous molecular assays, including the HopeSeq panels, which have enhanced City of Hope’s capacity for comprehensive molecular testing in solid tumors, hematologic cancers and hereditary cancer syndromes. These innovations have strengthened the institution’s leadership in precision medicine and cancer diagnostics.
Dr. Telatar earned her doctorate in human genetics from Bogazici University in Istanbul, Turkey, where she also received the university’s Ph.D. Thesis Award. She went on to complete a molecular genetics fellowship at the University of California, Los Angeles, followed by additional training through the institute’s Intercampus Medical Genetics Program. She also completed a research and development fellowship with the Lymphoma Research Foundation of America.
A fellow of the American College of Medical Genetics and Genomics, Dr. Telatar is also an active member of the American Society of Human Genetics and the Association for Molecular Pathology. She has authored peer-reviewed publications, abstracts and book chapters, and her research has been supported by grants from the National Institutes of Health and the Centers for Disease Control and Prevention.